Robert Carter, MD
Vascular Surgery · Kansas City, MONPI 1083645402
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $29,209 of the $48,039 with a category attached, or 60.8%. 41 manufacturers reported payments, led by Endologix LLC at 59.7% of the total. Reporting peaked in 2019 at $17,800 and has fallen 80.8% since, to $3,426 in 2025.
Across 234 payments — averaging $205.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Endologix LLC$29K
- Bard Peripheral Vascular, Inc.$9K
- Medtronic$2K
- W. L. Gore & Associates, Inc.$1K
- Silk Road Medical, Inc.$904
- Angiodynamics, Inc.$777
- plus $5K from 35 others
What the payments were for
- Consulting fees$29,20961%
- Travel & lodging$5411%
- Food & beverage$18,28938%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AFX$14,366
- AFX2 Bifurcated Endograft System$9,074
- CROSSER$4,251
- Alto Abdominal Stent Graft System$2,515
- ENDURANT IIS$1,438
- Dayspring$1,179
- Torus Stent Graft System$1,065
- ENDOCROSS Device$873
- ENROUTE Transcarotid Neuroprotection System$728
- Auryon Laser System 100-120 Vac$673
- ENROUTE Transcarotid Stent$582
- Ovation$420
- Koya Medical$393
- FLOWTRIEVER CATHETER, S$372
- CT THROMBECTOMY SYSTEM KIT$372
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$352
- ALTO$318
- GORE VIABAHN VBX Balloon Expandable Endo$312
- ENHANCE Transcarotid Peripheral Access Kit$305
- Indigo System$287
How this compares
$48,039 in reported general payments places this provider in the 85th percentile of 92 vascular surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 46 | $44,012 |
| ClopidogrelClopidogrel Bisulfate | 145 | $1,517 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 68 | $614 |
| Cephalexin | 101 | $221 |
| Methylprednisolone | 28 | $189 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 19 | $108 |
| Clindamycin Hcl | 54 | $90 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 36 | $72 |
| Tramadol Hcl | 15 | $43 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Kansas City
- Robert AndersonKansas City$23K
- Peter LauKansas City$23K
- Karthik VamananKansas City$7K
- Garrett TibbetsKansas City$7K
- Jamal MalikKansas City$4K
- Jeffrey JimSaint Louis$1.2M
- Karl StarkNorth Kansas City$223K
- Brian PetersonSaint Louis$216K
- Luis SanchezSaint Louis$178K
- Catherine WittgenSaint Louis$139K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.